CD8A and neoplasm: Although the risk-allele-associated increases in large CD8+ T cell clone populations would be anticipated to provide a more cytotoxic response to both tumor and other tissues, we cannot discount a direct B cell-mediated role for increased irAE risk associated with this allele, supported by increased class switching and immunoglobulin chain mutations in carriers pre-treatment.